Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function

Area of Science:

• Molecular Biology
• Biochemistry
• Antisense Technology

Background:

• Oligonucleotide analogs are crucial for molecular biology, diagnostics, and pharmaceuticals, targeting disease-associated gene expression.
• Peptide nucleic acids (PNAs) are promising nucleic acid mimetics with superior DNA/RNA binding affinity due to their N-aminoethylglycine polyamide backbone.
• PNAs can displace DNA strands, facilitated by stable (PNA)2 x DNA triple helix formation.

Purpose of the Study:

• To investigate the properties and potential applications of PNA/DNA chimeras as novel oligonucleotide analogs.
• To evaluate the binding characteristics, cellular uptake, and enzymatic recognition of PNA/DNA chimeras.
• To explore the therapeutic potential of PNA/DNA chimeras, particularly their ability to induce RNase H cleavage.

Main Methods:

• Synthesis and characterization of PNA/DNA chimeras.
• Assessment of binding affinity to DNA and RNA targets.
• Evaluation of cellular uptake and solubility compared to pure PNAs.
• Testing of enzymatic recognition and functional assays, including RNase H cleavage.

Main Results:

• PNA/DNA chimeras exhibit improved aqueous solubility and cellular uptake compared to pure PNAs.
• Chimeras bind exclusively in an antiparallel orientation and show strong binding affinity, especially to RNA.
• PNA/DNA chimeras are recognized by nucleic acid processing enzymes and can function as primers.
• Unlike pure PNAs, PNA/DNA chimeras effectively stimulate RNase H cleavage of target RNA.

Conclusions:

• PNA/DNA chimeras represent a significant advancement over pure PNAs, offering enhanced physicochemical and biological properties.
• The ability of chimeras to induce RNase H cleavage enhances their potential as effective antisense agents.
• PNA/DNA chimeras hold promise for therapeutic applications in gene expression modulation and other molecular interventions.